Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial
Thomas C. Neylan, Anne Richards, Thomas J. Metzler, et al.
SLEEP (2020) Vol. 43, Iss. 10
Open Access | Times Cited: 22

Showing 22 citing articles:

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
Emmanuel Mignot, David Mayleben, Ingo Fietze, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 2, pp. 125-139
Closed Access | Times Cited: 145
Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 25
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
Catherine Roch, Giorgio Bergamini, Michel A. Steiner, et al.
Psychopharmacology (2021) Vol. 238, Iss. 10, pp. 2693-2708
Open Access | Times Cited: 50
The sleep and circadian problems of Huntington’s disease: when, why and their importance
Zanna Voysey, Shaline V. Fazal, Alpár S. Lázár, et al.
Journal of Neurology (2020) Vol. 268, Iss. 6, pp. 2275-2283
Open Access | Times Cited: 35
The Treatment of Sleep Dysfunction in Neurodegenerative Disorders
Zanna Voysey, Roger A. Barker, Alpár S. Lázár
Neurotherapeutics (2020) Vol. 18, Iss. 1, pp. 202-216
Open Access | Times Cited: 29
Sleep Dysfunction in Huntington’s Disease: Impacts of Current Medications and Prospects for Treatment
Natalia E. Owen, Roger A. Barker, Zanna Voysey
Journal of Huntington s Disease (2023) Vol. 12, Iss. 2, pp. 149-161
Open Access | Times Cited: 9
Daridorexant for the Treatment of Insomnia
Christopher L. Robinson, Rajesh Supra, Evan Downs, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 15
Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials
Zhaoyang Huang, Shuqin Zhan, Chunyan Chen, et al.
SLEEP (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 6
Differential sleep/wake response and sex differences following acute suvorexant, MK‐1064 and zolpidem administration in the rTg4510 mouse model of tauopathy
Ryan J. Keenan, Heather Daykin, Jiahui Chu, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 13, pp. 3403-3417
Open Access | Times Cited: 10
Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation
Amy C. Beckenstrom, Preciosa Coloma, Gerard R. Dawson, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 147, pp. 105107-105107
Open Access | Times Cited: 5
Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
Yanpeng Li, Ruoxi Zhang, Zhou Yanling, et al.
SLEEP (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 5
Cross talk mechanism of disturbed sleep patterns in neurological and psychological disorders
Mehar Sahu, Rahul Tripathi, Niraj Kumar Jha, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104767-104767
Closed Access | Times Cited: 8
Dimdazenil for the treatment of insomnia: a systematic review and narrative synthesis
Suzhen Ran, Shouhuan Liu, Kevin Yan, et al.
Neurological Sciences (2024)
Closed Access | Times Cited: 1
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning
Hubert Bland, Xiaodong Li, Eric Mangin, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 4, pp. 414-420
Closed Access | Times Cited: 10
Rethinking the use of hypnotics for treatment of insomnia in the elderly
Dieter Kunz
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 8, pp. 953-957
Closed Access | Times Cited: 7
Latent Neuropsychological Profiles to Discriminate Mild Traumatic Brain Injury and Posttraumatic Stress Disorder in Active-Duty Service Members
Carrie Esopenko, Nicola L. de Souza, Yuane Jia, et al.
Journal of Head Trauma Rehabilitation (2022)
Open Access | Times Cited: 4
Cognitive and balance dysfunctions due to the use of zolpidem in the elderly: a systematic review
Guilherme Tavares, Gizela Kelmann, Francisco Tustumi, et al.
Dementia & Neuropsychologia (2021) Vol. 15, Iss. 3, pp. 396-404
Open Access | Times Cited: 4
A comprehensive review of Dual Orexin Receptor Antagonist (DORA), Daridorexant: Novel drug for sleep and related disorders
Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
International journal of life sciences, biotechnology and pharma research. (2024) Vol. 13, Iss. 6, pp. 20-29
Open Access
Increased Risk of Sudden Sensorineural Hearing Loss in Patients Receiving Sedative-Hypnotics: A Propensity Score Weighting Cohort Study
Huiwen Yang, Wen-Chi Huang, Kuan-Wei Chiang, et al.
Nature and Science of Sleep (2024) Vol. Volume 16, pp. 2231-2241
Open Access
Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis
Jing Li, Jing Li, Yulan Cui, et al.
Acta Pharmaceutica (2023) Vol. 73, Iss. 1, pp. 43-57
Open Access
Investigation of the effect of the dual orexin receptor antagonist almorexant on ophthalmological, spermatogenic, and hormonal variables in healthy male subjects
Jasper Dingemanse, Pascal Charef, Jed Black, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110955-110955
Open Access
Augmentation With Dual Orexin Receptor Antagonist for Sundown Syndrome
Yen‐Wei Li, Ta‐Chuan Yeh
American Journal of Therapeutics (2022) Vol. 30, Iss. 5, pp. e459-e461
Closed Access
Page 1

Scroll to top